Connective tissue remodelling is differently modulated by tocilizumab versus methotrexate monotherapy in patients with early rheumatoid arthritis: the AMBITION study
Abstract Objective Associations between rheumatoid arthritis (RA) and effect of treatment at the tissue levels are poorly understood. We investigated the scope of released extracellular matrix (ECM) metabolites as a consequence of tissue remodelling in patients treated with methotrexate (MTX) and to...
Main Authors: | Patryk J. Drobinski, Anne C. Bay-Jensen, Morten A. Karsdal, Samra Sardar, Anne S. Siebuhr |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13075-020-02378-7 |
Similar Items
-
Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab
by: Benucci M, et al.
Published: (2016-03-01) -
Administration Timing and Efficacy of Tocilizumab in Patients With COVID-19 and Elevated IL-6
by: Pan Li, et al.
Published: (2021-04-01) -
Methotrexate and The Lung in Rheumatoid Arthritis
by: Shamma Ahmad Al Nokhatha, et al.
Published: (2020-07-01) -
Addition of Tocilizumab to the Standard of Care Reduces Mortality in Severe COVID-19: A Systematic Review and Meta-Analysis
by: Umesha Boregowda, et al.
Published: (2020-10-01) -
Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
by: Dimitrios A. Pappas, et al.
Published: (2020-03-01)